CATAPLEXY

Clinical trials for CATAPLEXY explained in plain language.

Never miss a new study

Get alerted when new CATAPLEXY trials appear

Sign up with your email to follow new studies for CATAPLEXY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug shows promise for reducing narcolepsy attacks in long-term trial

Symptom relief Completed

This study looked at the long-term safety and effectiveness of a drug called AXS-12 for people with narcolepsy who also have cataplexy (sudden muscle weakness) and excessive daytime sleepiness. The 68 participants had already completed an earlier study and continued taking AXS-12…

Matched conditions: CATAPLEXY

Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief

Last updated Apr 29, 2026 15:02 UTC

CATAPLEXY

Get alerted when new CATAPLEXY trials appear

New drug shows promise for reducing narcolepsy attacks in long-term trial